Colonization of gnotobiotic mice with human gut microflora at birth protects against Escherichia coli heat-labile enterotoxin-mediated abrogation of oral tolerance

被引:21
作者
Gaboriau-Routhiau, V [1 ]
Raibaud, P [1 ]
Dubuquoy, C [1 ]
Moreau, MC [1 ]
机构
[1] INRA, Unite Ecol & Physiol Syst Digestif, F-78352 Jouy En Josas, France
关键词
D O I
10.1203/01.PDR.0000086902.52137.C9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Previous work has shown that the indigenous gut microflora in mice plays a protective role against Escherichia coli heat-labile enterotoxin (LT)-mediated abrogation of oral tolerance to an unrelated co-ingested protein. To assess potential protection by human gut microflora, we studied the effect of human gut microflora. in a marine model. Oral tolerance was studied in adult gnotobiotic mice (i.e. ex-germ-free mice) colonized with the entire human fecal microflora and orally administered once with LT and ovalbumin. Systemic suppression of IgG, IgG1, IgG2a, and IgE antibody responses was assessed by ELISA. Both specific IgG subclasses and IgE hyporesponsiveness was induced in LT + ovalbumin-fed gnotobiotic mice, indicating that the human gut microflora can protect against the LT-mediated abrogation of oral tolerance. However, as confirmed with mouse gut microflora, this protective effect only occurs when the gut microflora is associated from birth on. Colonization of germ-free mice with a single bacterial strain, E. coli, predominant in the human and mouse gut microflora. in the neonatal period, showed that this strain alone did not induce protection. These results supported the hypothesis that the natural establishment of the gut microflora in neonates crucially influenced resistance to LT-mediated abrogation of oral tolerance by reinforcing suppression of both T helper type 1- and T helper type 2-controlled responses, and suggested that sequential bacterial colonization of the gut rather than a single bacterial species may be involved in this phenomenon.
引用
收藏
页码:739 / 746
页数:8
相关论文
共 44 条
[1]   EFFECT OF ERYTHROMYCIN ON MICROBIAL ANTAGONISMS - A STUDY IN GNOTOBIOTIC MICE ASSOCIATED WITH A HUMAN FECAL FLORA [J].
ANDREMONT, A ;
RAIBAUD, P ;
TANCREDE, C .
JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (03) :579-587
[2]   ANTI-IL-10 TREATMENT DOES NOT BLOCK EITHER THE INDUCTION OR THE MAINTENANCE OF ORALLY INDUCED TOLERANCE TO OVA [J].
AROEIRA, LS ;
CARDILLO, F ;
DEALBUQUERQUE, DA ;
VAZ, NM ;
MENGEL, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 41 (04) :319-323
[3]   IMPACT OF BIFIDOBACTERIUM-LONGUM ON HUMAN FECAL MICROFLORA [J].
BENNO, Y ;
MITSUOKA, T .
MICROBIOLOGY AND IMMUNOLOGY, 1992, 36 (07) :683-694
[4]   Environment and infant immunity [J].
Björkstén, B .
PROCEEDINGS OF THE NUTRITION SOCIETY, 1999, 58 (03) :729-732
[5]  
Björkstén B, 1999, J ALLERGY CLIN IMMUN, V104, P1119
[6]   ADJUVANT ACTIVITY OF ESCHERICHIA-COLI HEAT-LABILE ENTERO-TOXIN AND EFFECT ON THE INDUCTION OF ORAL TOLERANCE IN MICE TO UNRELATED PROTEIN ANTIGENS [J].
CLEMENTS, JD ;
HARTZOG, NM ;
LYON, FL .
VACCINE, 1988, 6 (03) :269-277
[7]   THE ROLE OF HELPER T-CELL PRODUCTS IN MOUSE B-CELL DIFFERENTIATION AND ISOTYPE REGULATION [J].
COFFMAN, RL ;
SEYMOUR, BWP ;
LEBMAN, DA ;
HIRAKI, DD ;
CHRISTIANSEN, JA ;
SHRADER, B ;
CHERWINSKI, HM ;
SAVELKOUL, HFJ ;
FINKELMAN, FD ;
BOND, MW ;
MOSMANN, TR .
IMMUNOLOGICAL REVIEWS, 1988, 102 :5-28
[8]   Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants [J].
Douce, G ;
Giannelli, V ;
Pizza, M ;
Lewis, D ;
Everest, P ;
Rappuoli, R ;
Dougan, G .
INFECTION AND IMMUNITY, 1999, 67 (09) :4400-4406
[9]  
ELSON CO, 1984, J IMMUNOL, V133, P2892
[10]  
Finegold S.M., 1983, HUMAN INTESTINAL MIC, P3